Maxivate Topical Ointment 0.05pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Maxivate: Topical ointment (0.05%)

Detailed Information
Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

BETAMETHASONE (bay ta METH a sone) is a corticosteroid. It is used on the skin to treat swelling, redness, itching, and allergic reactions.

In-Depth Information

Maxivate 0.05% Topical Ointment

NDC: 000729450
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)




Labeled but not FDA approved for the following conditions:
Contact Dermatitis, Keloids, Mycosis Fungoides, Alopecia, Rhus Dermatitis, Necrobiosis Lipoidica Diabeticorum, Eczema, Pemphigus, Cutaneous T-cell Lymphoma (CTCL), Discoid Lupus Erythematosus, Granuloma Annulare, Dermatitis Herpetiformis, Seborrheic Dermatitis, Pruritus, Pityriasis Rosea, Psoriasis, Lichen Simplex, Stevens-Johnson Syndrome, Atopic Dermatitis, Lichen Planus, Exfoliative Dermatitis

Maxivate 0.05% Topical Ointment
Close All Sections Show

Reported Side Effects for Maxivate 0.05% Topical Ointment

Close Show
Thinning Of Skin Incidence:
<33.0%*
Severity: SEVERE
Onset: DELAYED
Hypothalamic-pituitary-adrenal (HPA) Suppression Incidence:
<73.0%*
Severity: MODERATE
Onset: DELAYED
Rash With Pustules Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
1.0-10.0%*
Severity: MILD
Onset: RAPID
Dry Skin Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Skin Irritation Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Skin Redness Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
Close Show
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Maxivate

Close Show

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5